–
Статьи в журналах
-
- 2020 Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
- Tkachuk Artem P., Bykonia Evgeniia N., Popova Liubov I., Kleymenov Denis A., Semashko Maria A., Chulanov Vladimir P., Fitilev Sergey B., Maksimov Semyon L., Smolyarchuk Elena A., Manuylov Victor A., Vasina Daria V., Gushchin Vladimir A., Gintsburg Alexander L.
- в журнале VACCINES, том 8, № 4, с. 652-652 DOI